文献速递肾癌与肾肿瘤

肾嗜酸细胞瘤主动监测中的生长与肾功能动态

Growth and renal function dynamics of renal oncocytomas in patients on active surveillance.
PubMed 文献 · BJU Int · 2021-08-09

本研究回顾性分析了98例肾嗜酸细胞瘤患者(101个病灶)主动监测的纵向数据,中位随访29个月。结论认为主动监测应视为7cm以下肾嗜酸细胞瘤的金标准管理。

要点

  • 肾嗜酸细胞瘤主动监测中肿瘤生长不影响肾功能。
  • 中位随访29个月,临床结局优异,仅少数病灶需干预。
  • 7cm以下肾嗜酸细胞瘤可考虑主动监测作为金标准。

核心结论

  • 肾嗜酸细胞瘤生长似乎不负面影响肾功能,中位随访超过2年临床结局优异。
  • 主动监测应被视为7cm以下肾嗜酸细胞瘤的金标准管理。

研究设计与样本

  • 回顾性队列研究,纳入2012至2019年Royal Free London NHS Foundation Trust肾脏癌症专科中心连续接受主动监测的肾嗜酸细胞瘤患者。
  • 分析98例患者共101个病灶的纵向数据,中位年龄69岁(IQR 13),男性占68.3%,中位随访29个月(IQR 26)。

主要发现

  • 64.4%的病灶生长,中位生长速率2mm/年(IQR 4)。
  • 肿瘤大小与eGFR随时间无关联(P=0.871)。
  • 9个病灶(8.9%)后续接受治疗,2例死亡均与肾嗜酸细胞瘤诊断无关。
  • 24%的病灶测量超过4cm,大多数为小肾肿块。

临床怎么用

  • 对于7cm以下的肾嗜酸细胞瘤,主动监测可作为金标准管理策略。
  • 监测期间无需因肿瘤生长而过度担心肾功能损害。

局限性

  • 回顾性研究设计。
  • 样本量有限(98例患者)。
  • 中位随访时间较短(29个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To study the natural history of renal oncocytomas and address indications for intervention by determining how growth is associated with renal function over time, the reasons for surgery and ablation, and disease-specific survival. PATIENTS AND METHODS: The study was conducted in a retrospective cohort of consecutive patients with renal oncocytoma on active surveillance reviewed at the Specialist Centre for Kidney Cancer at the Royal Free London NHS Foundation Trust (2012 to 2019). Comparison between groups was performed using Mann-Whitney U-tests and chi-squared tests. A mixed-effects model with a random intercept for patient was used to study the longitudinal association between tumour size and estimated glomerular filtration rate (eGFR). RESULTS: Longitudinal data from 98 patients with 101 lesions were analysed. Most patients were men (68.3%) and the median (interquartile range [IQR]) age was 69 (13) years. The median (IQR) follow-up was 29 (26) months. Most lesions were small renal masses, and 24% measured over 4 cm. Over half (64.4%) grew at a median (IQR) rate of 2 (4) mm per year. No association was observed between tumour size and eGFR over time (P = 0.871). Nine lesions (8.9%) were subsequently treated. Two deaths were reported, neither were related to the diagnosis of renal oncocytoma. CONCLUSION: Natural history data from the largest active surveillance cohort of renal oncocytomas to date show that renal function does not seem to be negatively impacted by growing oncocytomas, and confirms clinical outcomes are excellent after a median follow-up of over 2 years. Active surveillance should be considered the 'gold standard' management of renal oncocytomas up to 7cm.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Neves JB, Varley R, Agnesi S, et al. Growth and renal function dynamics of renal oncocytomas in patients on active surveillance. BJU Int. 2021. PMID: 34046981. doi:10.1111/bju.15499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。